Mettler-Toledo International Inc. (MTD) Earnings
Mettler-Toledo International Inc. is expected to report next earnings on July 30, 2026 (in NaN days), with a consensus EPS estimate of $10.78. MTD has beaten EPS estimates in 10 of its last 12 reported quarters (average surprise +4.2% over the last four).
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 8, 2026 | $8.70 | $8.91 | +2.4% | $947M | +0.4% |
| Feb 5, 2026 | $12.76 | $13.36 | +4.7% | $1.1B | +20.3% |
| Nov 6, 2025 | $10.66 | $11.15 | +4.6% | $1.0B | +3.3% |
| Jul 31, 2025 | $9.60 | $10.09 | +5.1% | $983M | +2.7% |
| May 1, 2025 | $7.88 | $8.19 | +3.9% | $884M | +0.8% |
| Feb 6, 2025 | $11.72 | $12.41 | +5.9% | $1.0B | +3.6% |
| Nov 8, 2024 | $10.01 | $10.21 | +2.0% | $955M | +1.0% |
| Aug 1, 2024 | $9.03 | $9.65 | +6.9% | $947M | +1.9% |
| May 9, 2024 | $7.64 | $8.89 | +16.4% | $926M | +5.3% |
| Feb 8, 2024 | $10.10 | $9.40 | -6.9% | $935M | -2.5% |
| Nov 9, 2023 | $9.74 | $9.80 | +0.6% | $942M | -1.0% |
| Jul 27, 2023 | $9.97 | $10.19 | +2.2% | $982M | -6.0% |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.
Earnings call summary
Q1 FY2026 · May 8, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
Patrick mentioned being pleased with first quarter results, solid execution of margin initiative, investments in innovation providing benefits, and being well positioned for future. Sean covered financial results including sales, margins, R&D, SG&A, adjusted operating profit, EPS, and adjusted free cash flow. Patrick then commented on operating businesses, noting modest growth across most product categories in lab with strong growth in bioprocessing, industrial core industrial having cautious customer purchasing patterns, product inspection having solid growth, and food retail strong sales growth. Also discussed investments in innovation like R&D accelerator and Jetstream programs, and new innovative products like EasyMax advanced automated lab reactor, in-motion PX1 auto-assembler, low retention pipette chips, and product inspection innovations.
Guidance
Full year 2026 local currency sales growth forecast remains at approximately 4% with acquisitions contributing ~1.5% in first half and <8% full year. Adjusted EPS forecast range $46.30 - $46.95, growth 8%-10%. Second quarter 2026 local currency sales expected to grow ~3% including ~1.5% from acquisitions. Adjusted EPS expected range $10.70 - $10.85, growth 6%-8%.
Segment performance
Sales in the quarter were $947 million, representing a 3% increase in local currency or 1% excluding acquisitions. Local currency sales increased 2% in the Americas, 1% in Europe, and 5% in Asia, rest of world including 4% growth in China. Excluding acquisitions, local currency sales were flat in the Americas and increased 3% in Asia, rest of world. Local currency sales increased 1% in laboratory, 5% in industrial (including 1% growth in core industrial and 11% growth in product inspection), and food retail grew 7% in the quarter. Gross margin was 58.7% in the quarter, a decrease of 80 basis points. Adjusted operating profit amounted to $246 million in the quarter, up 4% versus the prior year. Adjusted EPS for the quarter was $8.91, a 9% increase over the prior year.
Risks & headwinds
Increased uncertainty in macroeconomic environment, war in Middle East leading to higher global energy costs and market uncertainty, customer delays in first quarter, incremental tariff costs impacting operating profit and EPS.
Analyst Q&A
Q: Michael Riskin with Bank of America asked about full year guide and organic business.
A: Sean responded on acquisitions contribution and cautious approach due to uncertainty.
Q: Luke Sergot with Barclays asked about Americas retail dynamics and China strength.
A: Sean and Patrick responded on retail lumpy nature and China's industrial automation and pharma opportunities.
Q: Catherine Schult with Baird asked about pipeline activity and Europe chemical softness.
A: Patrick responded on pipeline activity and chemical softness due to higher energy costs.
Q: Dan Arias with Stifel asked about cost management.
A: Sean responded on cost management and price mitigation.
Q: Patrick Donnelly with City asked about core industrial and China.
A: Patrick responded on core industrial automation and China's automation momentum.
Q: Vijay Kumar with Evercore ISI asked about lab performance and China.
A: Patrick responded on lab headwinds and China's bioprocessing investments.
Q: Callum Titchmarsh with Morgan Stanley asked about service demand and reshoring.
A: Patrick and Sean responded on service growth and reshoring early innings.
Q: Josh Waldman with Cleveland Research asked about PI growth durability.
A: Patrick responded on PI growth durability due to innovation.
Q: Doug Shankle with Wolf Research asked about pacing and China grant.
A: Sean responded on pacing and China grant details.
Q: Tycho Pearson with Jefferies asked about customer delays and chemical softness.
A: Tycho and Patrick responded on customer delays and chemical softness.
Q: Evie Koslowski with Goldman Sachs asked about semiconductor exposure and bioprocessing.
A: Patrick responded on semiconductor exposure and bioprocessing demand.
Q: Brandon Couillard with Wells Fargo asked about China lab and bioprocessing.
A: Sean and Patrick responded on China lab and bioprocessing performance.
Q: Casey Woodring with JP Morgan asked about incremental tariff.
A: Sean responded on incremental tariff components